The concentrations of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase are increased in patients with coronary artery disease (CAD). An elevated concentration of ADMA in the plasma and pericardial fluid (PF) is an independent predictor of worse cardiovascular events in patients undergoing coronary revascularization. We aimed to investigate the changes of pericardial and plasma ADMA levels in patients with CAD, who underwent percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) surgery. Patients and Methods: 64 patients who underwent PCI or CABG surgery were enrolled in this study (65.5 ± 8.2 years). 52 patients who underwent the valve replacement (VR) served as control subjects (59 ± 6.9 years). Exercise stress test was performed on a treadmill according to the Bruce protocol. ADMA levels were determined by using liquid chromatography -tandem mass spectrometry. Furthermore L-arginine and ADMA concentrations were determined in plasma and PF of patients undergoing coronary artery bypass graft (CABG, n=28) or valve replacement (VR, n=25).
